4D Molecular Therapeutics

4D Molecular Therapeutics company information, Employees & Contact Information

4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations. We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together: - Dare to Cure - Break Boundaries - Beyond Yourself - Prepare & Execute Relentlessly Join us in creating the future of genetic medicine.

Company Details

Employees
224
Founded
-
Address
5858 Horton St,
Phone
(510) 505-2680
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Emeryville, California
Looking for a particular 4D Molecular Therapeutics employee's phone or email?

4d Molecular Therapeutics Questions

News

4DMT Announces New Employment Inducement Grants - GlobeNewswire

4DMT Announces New Employment Inducement Grants GlobeNewswire

4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference - Stock Titan

4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference Stock Titan

4D Molecular Therapeutics: A Smart Bet On Long-Term VEGF Suppression - Seeking Alpha

4D Molecular Therapeutics: A Smart Bet On Long-Term VEGF Suppression Seeking Alpha

Late-Stage Biotech 4DMT Announces Triple Conference Schedule: Cantor, H.C. Wainwright, Morgan Stanley - Stock Titan

Late-Stage Biotech 4DMT Announces Triple Conference Schedule: Cantor, H.C. Wainwright, Morgan Stanley Stock Titan

4DMT Announces Accelerated 4D-150 Phase 3 Development in - GlobeNewswire

4DMT Announces Accelerated 4D-150 Phase 3 Development in GlobeNewswire

4DMT Announces Leadership Expansion with Proven Late-Stage - GlobeNewswire

4DMT Announces Leadership Expansion with Proven Late-Stage GlobeNewswire

4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewswire

4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones GlobeNewswire

4DMT to Participate in Upcoming Investor Conferences - GlobeNewswire

4DMT to Participate in Upcoming Investor Conferences GlobeNewswire

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewswire

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones GlobeNewswire

4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME - GlobeNewswire

4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME GlobeNewswire

4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD - GlobeNewswire

4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD GlobeNewswire

4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV - GlobeNewswire

4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV GlobeNewswire

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update - GlobeNewswire

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update GlobeNewswire

4D Molecular Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference Panel Discussions - Quiver Quantitative

4D Molecular Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference Panel Discussions Quiver Quantitative

4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewswire

4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock GlobeNewswire

4D-150 Reduces Injection Burden in DME, Paving Way for FDA-Backed Phase 3 - HCPLive

4D-150 Reduces Injection Burden in DME, Paving Way for FDA-Backed Phase 3 HCPLive

4D Molecular Therapeutics Announces Presentations at ASRS 2025 on Phase 2 Clinical Trials for 4D-150 in Diabetic Macular Edema and Neovascular Age-related Macular Degeneration - Quiver Quantitative

4D Molecular Therapeutics Announces Presentations at ASRS 2025 on Phase 2 Clinical Trials for 4D-150 in Diabetic Macular Edema and Neovascular Age-related Macular Degeneration Quiver Quantitative

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation - GlobeNewswire

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation GlobeNewswire

4D Molecular Therapeutics’ Wet AMD Gene Therapy 4D-150 Reduces Need for antiVEGF Injections - CGTLive®

4D Molecular Therapeutics’ Wet AMD Gene Therapy 4D-150 Reduces Need for antiVEGF Injections CGTLive®

Jim Cramer on 4D Molecular Therapeutics: “This is a Pure Spec” - Yahoo Finance

Jim Cramer on 4D Molecular Therapeutics: “This is a Pure Spec” Yahoo Finance

4DMT Advances Leadership in Large Market Ophthalmology with - GlobeNewswire

4DMT Advances Leadership in Large Market Ophthalmology with GlobeNewswire

4DMT to Participate in the 2024 Cantor Global Healthcare Conference - Stock Titan

4DMT to Participate in the 2024 Cantor Global Healthcare Conference Stock Titan

4DMT links gene therapy to drop in Eylea injections, fueling plans to enter phase 3 - Fierce Biotech

4DMT links gene therapy to drop in Eylea injections, fueling plans to enter phase 3 Fierce Biotech

4D Molecular Therapeutics: Promising Preliminary Safety & Efficacy For 4D-310 - Seeking Alpha

4D Molecular Therapeutics: Promising Preliminary Safety & Efficacy For 4D-310 Seeking Alpha

4DMT shares data from Phase 1/2 PRISM clinical trial, 4FRONT Phase 3 study design - Modern Retina

4DMT shares data from Phase 1/2 PRISM clinical trial, 4FRONT Phase 3 study design Modern Retina

Aerosol gene therapy safe, heightens CFTR protein levels in cystic fibrosis - Healio

Aerosol gene therapy safe, heightens CFTR protein levels in cystic fibrosis Healio

4D Molecular Therapeutics Announces Closing of Initial - GlobeNewswire

4D Molecular Therapeutics Announces Closing of Initial GlobeNewswire

4D Molecular Therapeutics: Market Expects Wet AMD Gene Therapy Failure - I'm Not So Sure - Seeking Alpha

4D Molecular Therapeutics: Market Expects Wet AMD Gene Therapy Failure - I'm Not So Sure Seeking Alpha

FDMT - 4D Molecular Therapeutics Inc. Latest Stock News & Market Updates - Stock Titan

FDMT - 4D Molecular Therapeutics Inc. Latest Stock News & Market Updates Stock Titan

FDMT Stock Price and Chart — NASDAQ:FDMT - TradingView

FDMT Stock Price and Chart — NASDAQ:FDMT TradingView

Top 4D Molecular Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant